SCHEMBL17001677

SCHEMBL17001677

CN1CCC(C2CCCN2C(=O)NCC(F)(F)F)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.43
▸ RAB9A P51151 1/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ HCRTR2 O43614 1/20 0.41
▸ POLB P06746 1/20 0.37
▸ TDP1 Q9NUW8 1/20 0.37
▸ ULK1 O75385 1/20 0.36
▸ HRH3 Q9Y5N1 3/20 0.35
▸ HSD11B1 P28845 2/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ JAK2 O60674 2/20 0.34
▸ JAK1 P23458 2/20 0.34
▸ TYK2 P29597 1/20 0.34
▸ JAK3 P52333 1/20 0.34
▸ RIPK1 Q13546 1/20 0.34
▸ FKBP1A P62942 1/20 0.34
▸ PREP P48147 1/20 0.33
▸ FAP Q12884 1/20 0.33
▸ ITGB3 P05106 1/20 0.33
▸ ITGA2B P08514 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18382159 1.00 NPC1 (0.43) NPC1RAB9ASMN1; SMN2HCRTR2POLB
SCHEMBL17001680 0.83 NPC1 (0.47) NPC1RAB9ASMN1; SMN2HCRTR2POLB
SCHEMBL17001664 0.82 NPC1 (0.44) NPC1RAB9ASMN1; SMN2POLBTDP1
SCHEMBL18382116 0.82 DRD2 (0.37) NPC1RAB9ASMN1; SMN2HCRTR2POLB
SCHEMBL20312939 0.82 DRD2 (0.37) NPC1RAB9ASMN1; SMN2HCRTR2POLB
SCHEMBL18382059 0.81 NPC1 (0.43) NPC1RAB9ASMN1; SMN2POLBTDP1
SCHEMBL17001679 0.78 SMN1; SMN2 (0.50) NPC1RAB9ASMN1; SMN2HCRTR2POLB
SCHEMBL17001678 0.78 SMN1; SMN2 (0.50) NPC1RAB9ASMN1; SMN2HCRTR2POLB
SCHEMBL17001674 0.78 SMN1; SMN2 (0.50) NPC1RAB9ASMN1; SMN2HCRTR2POLB
SCHEMBL17001673 0.77 KDM4E (0.45) NPC1RAB9ASMN1; SMN2HCRTR2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015118342-A1 BICYCLIC AZA COMPOUNDS AS MUSCARINIC M1 RECEPTOR AGONISTS. HEPTARES THERAPEUTICS LIMITED (GB) 2015-08-13 — — WO disclosed
Send feedback